新诊断的卵巢交界性肿瘤中的微乳头状模式：名称中有何含义？
Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?
出版信息
Oncologist. 2011;16(2):133-5. doi: 10.1634/theoncologist.2010-0410. Epub 2011 Jan 27.
Abstract
The study by Uzan and colleagues published in this issue of on the prognosis of patients with serous borderline tumors of the ovary with a micropapillary pattern is reviewed.
摘要
乌赞及其同事在本期《柳叶刀肿瘤学》杂志上发表的关于具有微乳头状模式的卵巢浆液性交界性肿瘤患者预后的研究进行了回顾。
相似文献
1
Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?新诊断的卵巢交界性肿瘤中的微乳头状模式：名称中有何含义？
Oncologist. 2011;16(2):133-5. doi: 10.1634/theoncologist.2010-0410. Epub 2011 Jan 27.
2
Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns.具有微乳头和筛状模式的卵巢浆液性交界性肿瘤：40例研究及与44例无这些模式的病例对比。
Am J Surg Pathol. 1999 Apr;23(4):397-409. doi: 10.1097/00000478-199904000-00004.
3
Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.Ⅱ期和Ⅲ期浆液性交界性卵巢肿瘤患者中微乳头模式的预后和预后因素。
Oncologist. 2011;16(2):189-96. doi: 10.1634/theoncologist.2009-0139. Epub 2011 Jan 27.
4
Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.卵巢浆液性交界性肿瘤：137例长期随访研究，其中18例具有微乳头模式，20例有微浸润。
Am J Surg Pathol. 2002 Sep;26(9):1111-28. doi: 10.1097/00000478-200209000-00002.
5
Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.卵巢微乳头浆液性癌。一种与浆液性交界性肿瘤相关的独特的低级别癌。
Am J Surg Pathol. 1996 Nov;20(11):1319-30. doi: 10.1097/00000478-199611000-00003.
6
A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component.对57例有和没有非侵袭性微乳头成分的浆液性交界性肿瘤的比较分析。
Am J Surg Pathol. 2002 May;26(5):592-600. doi: 10.1097/00000478-200205000-00005.
7
Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors).
Cancer. 2002 Aug 15;95(4):675-6. doi: 10.1002/cncr.10777.
8
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.卵巢浆液性交界性肿瘤分为良性和恶性类型。65例晚期病例的临床病理研究。
Am J Surg Pathol. 1996 Nov;20(11):1331-45. doi: 10.1097/00000478-199611000-00004.
9
Ovarian serous surface papillary borderline tumors form sea anemone-like masses.卵巢浆液性表面乳头状交界性肿瘤形成海葵样肿块。
J Magn Reson Imaging. 2011 Mar;33(3):633-40. doi: 10.1002/jmri.22430. Epub 2011 Feb 1.
10
Parovarian borderline malignancy in pregnancy.妊娠期卵巢旁交界性恶性肿瘤
Arch Gynecol Obstet. 1996;258(2):105-8. doi: 10.1007/BF00626032.
本文引用的文献
1
Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.Ⅱ期和Ⅲ期浆液性交界性卵巢肿瘤患者中微乳头模式的预后和预后因素。
Oncologist. 2011;16(2):189-96. doi: 10.1634/theoncologist.2009-0139. Epub 2011 Jan 27.
2
Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.Ⅱ期-Ⅳ期浆液性卵巢交界性肿瘤的复发模式及辅助化疗的作用。
Gynecol Oncol. 2010 Nov;119(2):270-3. doi: 10.1016/j.ygyno.2010.07.019. Epub 2010 Aug 16.
3
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.具有微乳头状特征的低恶性潜能肿瘤在分子水平上与卵巢低级别浆液性癌相似。
Gynecol Oncol. 2010 Apr;117(1):9-17. doi: 10.1016/j.ygyno.2010.01.006. Epub 2010 Feb 1.
4
Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.浆液性卵巢交界性肿瘤患者中微乳头模式的预后意义。
Acta Obstet Gynecol Scand. 2008;87(4):476-81. doi: 10.1080/00016340801995640.
5
Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.卵巢或腹膜低级别浆液性癌的新辅助化疗。
Gynecol Oncol. 2008 Mar;108(3):510-4. doi: 10.1016/j.ygyno.2007.11.013. Epub 2007 Dec 26.
6
Recurrence and prognostic factors in borderline ovarian tumors.卵巢交界性肿瘤的复发及预后因素
Gynecol Oncol. 2005 Sep;98(3):439-45. doi: 10.1016/j.ygyno.2005.05.033.
7
Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.卵巢低恶性潜能浆液性肿瘤（交界性肿瘤）：276例患者长期（≥5年）随访的基于结局的研究
Am J Surg Pathol. 2005 Jun;29(6):707-23. doi: 10.1097/01.pas.0000164030.82810.db.
8
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.p53 突变模式可区分卵巢浆液性交界性肿瘤以及低级别和高级别癌，并为卵巢癌发生的新模型提供支持：一项免疫组化相关性突变分析
Am J Surg Pathol. 2005 Feb;29(2):218-24. doi: 10.1097/01.pas.0000146025.91953.8d.
9
Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.卵巢非侵袭性和侵袭性微乳头（低级别）浆液性癌：135例临床病理分析
Am J Surg Pathol. 2003 Jun;27(6):725-36. doi: 10.1097/00000478-200306000-00003.
10
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.BRAF和KRAS基因的突变是低级别卵巢浆液性癌发展的特征。
J Natl Cancer Inst. 2003 Mar 19;95(6):484-6. doi: 10.1093/jnci/95.6.484.
Zotero 插件